Skip to main content
Adam Mamelak, MD, Neurosurgery, Los Angeles, CA

AdamMamelakMD

Neurosurgery Los Angeles, CA

Brain & Spinal Tumor, Pituitary Surgery, Skull Base, Stereotactic & Functional Neurosurgery

Professor of Neurosurgery Cedars-Sinai Medical Center

Dr. Mamelak is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Mamelak's full profile

Already have an account?

  • Office

    8700 Beverly Blvd
    Los Angeles, CA 90048
    Phone+1 310-423-7900
    Fax+1 310-423-0810

Education & Training

  • University of California (San Francisco)
    University of California (San Francisco)Residency, Neurological Surgery, 1990 - 1996
  • Harvard Medical School
    Harvard Medical SchoolClass of 1990

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1991 - 2025
  • OR State Medical License
    OR State Medical License 2020 - 2022
  • American Board of Neurological Surgery Neurological Surgery

Awards, Honors, & Recognition

  • America's Top Doctors Castle Connolly, 2006-2014
  • Top Doctors:LA Area Castle Connolly, 2013
  • America's Top Doctors for Cancer Castle Connolly, 2005-2013
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Consensus-Driven in-Hospital Cortisol Assessment After ACTH-Secreting Pituitary Adenoma Resection  
    Adam N Mamelak, Yana Stolyarov, Pituitary

Press Mentions

  • Q&A: New Frontiers in ALS Research
    Q&A: New Frontiers in ALS ResearchJune 13th, 2024
  • New Neurosurgery Research: Surgical Versus Nonsurgical Treatment of Pituitary Apoplexy
    New Neurosurgery Research: Surgical Versus Nonsurgical Treatment of Pituitary ApoplexyApril 24th, 2023
  • Cedars Gets $12 Million for ALS Clinical Trial
    Cedars Gets $12 Million for ALS Clinical TrialJune 24th, 2021
  • Join now to see all

Professional Memberships

Other Languages

  • Hebrew